PEANUT ALLERGY

This study is testing a skin patch called Viaskin that delivers a tiny amount of peanut protein to help 1-3 year olds with peanut allergy. The goal is to see if the patch is safe over 6 months. About 480 children will wear the patch or a placebo daily. This is a phase 3 trial, me…

This study tests whether giving children small daily doses of peanut or cow's milk from common foods (like cereal or whole peanuts) can help them tolerate these allergens. It involves 216 children aged 3-23 with peanut or cow's milk allergy. The goal is to see if this simple appr…

This study follows 500 people aged 6 months to 65 years with peanut allergy who are undergoing peanut oral immunotherapy. The goal is to see how many can tolerate a maintenance dose of 300 mg of peanut protein without symptoms within two years. Researchers also track changes in q…

This early-stage trial tests a new vaccine called VLP Peanut in 46 healthy adults and people with peanut allergy. The goal is to see if it is safe and tolerable, and to get an early look at whether it might reduce allergic reactions. Participants receive injections of the vaccine…

This phase 2 trial tests a new treatment called PVX108 for children and teens with peanut allergy. The treatment uses small pieces of peanut protein to help the immune system become less reactive. About 90 participants will receive either PVX108 or a placebo, and researchers will…